Search
Now showing items 1-1 of 1
Biologics and Biosimilars as Treatment Options for Psoriasis
(Brac University, 2022-02)
Psoriasis is a common chronic skin disease stemming from a systemic inflammatory disorder.
It affects more than 7.5 million people in the United States and an estimated 125 million
people worldwide. It is an immune-mediated ...